Hepatocellular carcinoma (Q33601735)

28 July 2017

1 reference

title

Hepatocellular carcinoma (English)

1 reference

28 July 2017

D F Schafer

1

1 reference

PubMed ID

10217098

28 July 2017

M F Sorrell

series ordinal

2

1 reference

PubMed ID

10217098

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

353

1 reference

28 July 2017

9160

1 reference

28 July 2017

1253-1257

1 reference

Cancer mortality among Chinese migrants: a review.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Long-term survival in patients with hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Three recently described animal virus models for human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Natural and experimental infection of wild mallard ducks with duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Alcohol, hepatotropic viruses, and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Characteristic features of alcoholic liver disease in Japan: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Liver cell dysplasia: a premalignant condition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Morphologic studies of the liver cell dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Hepatocellular carcinoma in cirrhotics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Detection of circulating albumin-mRNA by RT-PCR does not indicate metastasizing hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Blood supply of early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

Treatment of hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2909148-X

7 January 2021

10.1016/S0140-6736(98)09148-X

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10217098